Peptris is using AI to find drug candidates to shorten the time it takes for laboratory validation

Company Details Company Overview Founded 2019 Founders Narayanan Venkatasubramanian, Shridhar Narayanan, Anand Budni, Amit Mahajan Headquarters Bengaluru Sector AI-led preclinical drug discovery Funding Raised ₹70 crore Series A (February 2026); about ₹8 crore pre-seed (December 2023) Key Investors IAN Alpha Fund and Speciale Invest (Series A co-leads), Tenacity Ventures, BYT Ventures Lead Asset PEPR-124, licensed to Revio Therapeutics Therapeutic Areas Rare diseases, inflammation, oncology, wom